BSE Live
Mar 11, 16:01Prev. Close
378.55
Open Price
378.20
Bid Price (Qty.)
380.20 (1)
Offer Price (Qty.)
384.60 (1)
NSE Live
Mar 11, 15:48Prev. Close
378.65
Open Price
378.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Zydus Wellness (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 57.66 | 57.66 | 39.07 | 39.07 | 39.07 | |
| Total Share Capital | 57.66 | 57.66 | 39.07 | 39.07 | 39.07 | |
| Reserves and Surplus | 3,157.04 | 3,267.58 | 652.12 | 518.12 | 438.09 | |
| Total Reserves and Surplus | 3,157.04 | 3,267.58 | 652.12 | 518.12 | 438.09 | |
| Total Shareholders Funds | 3,214.70 | 3,325.24 | 691.19 | 557.19 | 477.16 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1,500.00 | 1,500.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.22 | 0.30 | 0.68 | 1.22 | |
| Other Long Term Liabilities | 1.09 | 0.57 | 0.50 | 0.54 | 0.42 | |
| Long Term Provisions | 1.94 | 0.27 | 0.28 | 0.15 | 0.11 | |
| Total Non-Current Liabilities | 1,503.03 | 1,501.06 | 1.08 | 1.37 | 1.75 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 16.30 | 66.50 | 25.00 | 25.00 | 0.00 | |
| Trade Payables | 32.97 | 24.68 | 16.25 | 15.43 | 11.46 | |
| Other Current Liabilities | 34.93 | 36.40 | 5.09 | 5.18 | 5.62 | |
| Short Term Provisions | 0.83 | 0.28 | 0.55 | 0.56 | 0.36 | |
| Total Current Liabilities | 85.03 | 127.86 | 46.89 | 46.17 | 17.44 | |
| Total Capital And Liabilities | 4,802.76 | 4,954.16 | 739.16 | 604.73 | 496.35 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 19.90 | 14.39 | 15.54 | 17.39 | 19.98 | |
| Intangible Assets | 22.82 | 22.85 | 22.88 | 22.92 | 22.97 | |
| Capital Work-In-Progress | 1.47 | 1.13 | 0.22 | 0.09 | 0.07 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 44.19 | 38.37 | 38.64 | 40.40 | 43.02 | |
| Non-Current Investments | 3,527.58 | 3,689.52 | 2.45 | 2.45 | 2.45 | |
| Deferred Tax Assets [Net] | 13.99 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 1,121.36 | 1,120.00 | 0.32 | 0.36 | 6.21 | |
| Other Non-Current Assets | 8.00 | 7.80 | 3.86 | 6.39 | 0.00 | |
| Total Non-Current Assets | 4,715.12 | 4,855.69 | 45.27 | 49.60 | 51.68 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 291.17 | 251.63 | 205.39 | |
| Inventories | 12.34 | 5.68 | 6.26 | 6.26 | 3.68 | |
| Trade Receivables | 0.55 | 6.29 | 1.04 | 0.46 | 0.27 | |
| Cash And Cash Equivalents | 29.80 | 42.98 | 392.20 | 294.78 | 233.64 | |
| Short Term Loans And Advances | 0.00 | 5.50 | 0.30 | 1.31 | 0.88 | |
| OtherCurrentAssets | 44.95 | 38.02 | 2.92 | 0.69 | 0.81 | |
| Total Current Assets | 87.64 | 98.47 | 693.89 | 555.13 | 444.67 | |
| Total Assets | 4,802.76 | 4,954.16 | 739.16 | 604.73 | 496.35 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 7.50 | 8.52 | 6.77 | 7.07 | 7.84 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 7.61 | 2.01 | 0.00 | 0.36 | 0.13 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | 0.09 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 9.71 | 3.45 | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 3,527.58 | 3,689.52 | 2.45 | 2.45 | 2.45 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | 94.16 | |
| Current Investments Unquoted Book Value | -- | -- | 143.62 | 221.62 | 112.65 |
26.02.2026
20.02.2026
19.02.2026
Zydus Lifesciences shares rise on final USFDA approval for Bosentan tablets
19.02.2026
05.02.2026
Zydus Wellness Consolidated December 2025 Net Sales at Rs 964.90 crore, up 108.9% Y-o-Y
04.02.2026
Zydus Wellness Standalone December 2025 Net Sales at Rs 152.60 crore, up 72.62% Y-o-Y
10.11.2025
Zydus Wellness Standalone September 2025 Net Sales at Rs 156.00 crore, up 146.45% Y-o-Y
31.07.2025
Zydus Wellness Standalone June 2025 Net Sales at Rs 87.70 crore, up 38.33% Y-o-Y
05.02.2026
Zydus Wellness Consolidated December 2025 Net Sales at Rs 964.90 crore, up 108.9% Y-o-Y
04.02.2026
Zydus Wellness Standalone December 2025 Net Sales at Rs 152.60 crore, up 72.62% Y-o-Y
10.11.2025
Zydus Wellness Standalone September 2025 Net Sales at Rs 156.00 crore, up 146.45% Y-o-Y
31.07.2025
Zydus Wellness Standalone June 2025 Net Sales at Rs 87.70 crore, up 38.33% Y-o-Y
12.04.2022
Zydus Wellness Q4 PAT may dip 0.4% YoY to Rs. 132.6 cr: ICICI Direct
13.07.2021
Zydus Wellness Q1 PAT seen up 36.3% YoY to Rs. 122 cr: Arihant Capital
12.07.2021
Zydus Wellness Q1 PAT seen up 54.1% YoY to Rs 137.5 cr: ICICI Direct
13.04.2021
Zydus Wellness Q4 PAT seen up 31.6% YoY to Rs 94.6 cr: Sharekhan
12.03.2026
Wanted to kill Farooq Abdullah for 20 years, says accused in Jammu wedding firing case
12.03.2026
12.03.2026
UN Security Council demands Iran halt Gulf attacks, Tehran calls resolution 'blatant misuse'
12.03.2026
Trump says Iran near defeat, warns US strikes could make rebuilding 'almost impossible'
12.04.2022
Zydus Wellness Q4 PAT may dip 0.4% YoY to Rs. 132.6 cr: ICICI Direct
13.07.2021
Zydus Wellness Q1 PAT seen up 36.3% YoY to Rs. 122 cr: Arihant Capital
12.07.2021
Zydus Wellness Q1 PAT seen up 54.1% YoY to Rs 137.5 cr: ICICI Direct
13.04.2021
Zydus Wellness Q4 PAT seen up 31.6% YoY to Rs 94.6 cr: Sharekhan
12.04.2022
Zydus Wellness Q4 PAT may dip 0.4% YoY to Rs. 132.6 cr: ICICI Direct
13.07.2021
Zydus Wellness Q1 PAT seen up 36.3% YoY to Rs. 122 cr: Arihant Capital
12.07.2021
Zydus Wellness Q1 PAT seen up 54.1% YoY to Rs 137.5 cr: ICICI Direct
13.04.2021
Zydus Wellness Q4 PAT seen up 31.6% YoY to Rs 94.6 cr: Sharekhan
12.04.2022
Zydus Wellness Q4 PAT may dip 0.4% YoY to Rs. 132.6 cr: ICICI Direct
13.07.2021
Zydus Wellness Q1 PAT seen up 36.3% YoY to Rs. 122 cr: Arihant Capital
12.07.2021
Zydus Wellness Q1 PAT seen up 54.1% YoY to Rs 137.5 cr: ICICI Direct
13.04.2021
Zydus Wellness Q4 PAT seen up 31.6% YoY to Rs 94.6 cr: Sharekhan